The Misuse of Drugs (Amendment No.3) (England, Wales and Scotland) Regulations 2012

• Citation: S.I. 2012/1311
• Sections: 5

Section 1 Citation, commencement and extent

(1) These Regulations may be cited as the Misuse of Drugs (Amendment No.3) (England, Wales and Scotland) Regulations 2012 and shall come into force on 13 th June 2012.

(2) These Regulations extend to England and Wales and Scotland.

Section 2 Amendments to the Misuse of Drugs Regulations 2001

The Misuse of Drugs Regulations 2001 shall be amended as follows.

Section 3 Amendments to the Misuse of Drugs Regulations 2001

In Schedule 1 (which specifies controlled drugs subject to the requirements of regulations 14, 15, 16, 18, 19, 20, 23, 26 and 27) after paragraph 1(n), insert—

(o) Any compound (not being pipradrol) structurally derived from piperidine, pyrrolidine, azepane, morpholine or pyridine by substitution at a ring carbon atom with a diphenylmethyl group, whether or not the compound is further modified in any of the following ways, that is to say,

(i) by substitution in any of the phenyl rings to any extent with alkyl, alkoxy, haloalkyl or halide groups;

(ii) by substitution at the methyl carbon atom with an alkyl, hydroxyalkyl or hydroxy group;

(iii) by substitution at the ring nitrogen atom with an alkyl, alkenyl, haloalkyl or hydroxyalkyl group.

Section 4 Amendments to the Misuse of Drugs Regulations 2001

In paragraph 1(a) of Schedule 3 (which specifies controlled drugs subject to the requirements of regulations 14, 15 (except Temazepam), 16, 18, 22, 23, 24, 26 and 27) after “Benzphetamine”, insert “7-bromo-5-(2-chlorophenyl)-1,3-dihydro-2 H -1,4-benzodiazepin-2-one”.

Section 5 Amendments to the Misuse of Drugs Regulations 2001

In Schedule 3 for paragraphs 2, 3 and 4, substitute—

(2) Any stereoisomeric form of a substance specified in paragraph 1 or 3 not being phenylpropanolamine.

(3) Any ester or ether of pipradrol.

(4) Any salt of a substance specified in any of paragraphs 1 to 3.

(5) Any preparation or other product containing a substance specified in any of paragraphs 1 to 4, not being a preparation specified in Schedule 5.